4.8 Article

Aberrant cannabinoid signaling impairs oviductal transport of embryos

Journal

NATURE MEDICINE
Volume 10, Issue 10, Pages 1074-1080

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nm1104

Keywords

-

Funding

  1. NCI NIH HHS [CA77839] Funding Source: Medline
  2. NICHD NIH HHS [HD37830, HD12304] Funding Source: Medline
  3. NIDA NIH HHS [DA06668] Funding Source: Medline

Ask authors/readers for more resources

Ectopic pregnancy is a major reproductive health issue. Although other underlying causes remain largely unknown, one cause of ectopic pregnancy is embryo retention in the fallopian tube. Here we show that genetic or pharmacologic silencing of cannabinoid receptor CB1 causes retention of a large number of embryos in the mouse oviduct, eventually leading to pregnancy failure. This is reversed by isoproterenol, beta-adrenergic receptor agonist. Impaired oviductal embryo transport is also observed in wild-type mice treated with methanandamide. Collectively, the results suggest that aberrant cannabinoid signaling impedes coordinated oviductal smooth muscle contraction and relaxation crucial to normal oviductal embryo transport. Colocalization of CB1 and beta2-adrenergic receptors in the oviduct muscularis implies that a basal endocannabinoid tone in collaboration with adrenergic receptors coordinates oviductal motility for normal journey of embryos into the uterus. Besides uncovering a new regulatory mechanism, this study could be clinically relevant to ectopic pregnancy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available